146 related articles for article (PubMed ID: 6537969)
1. Enhancement of hypophysectomy-induced dopamine receptor hypersensitivity in male rats by chronic haloperidol administration.
Gordon JH; Diamond BI
J Neurochem; 1984 Feb; 42(2):523-8. PubMed ID: 6537969
[TBL] [Abstract][Full Text] [Related]
2. Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogen.
Perry KO; Diamond BI; Fields JZ; Gordon JH
Brain Res; 1981 Dec; 226(1-2):211-9. PubMed ID: 7197571
[TBL] [Abstract][Full Text] [Related]
3. Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors.
Di Paolo T; Daigle M; Labrie F
Psychoneuroendocrinology; 1984; 9(4):399-404. PubMed ID: 6514934
[TBL] [Abstract][Full Text] [Related]
4. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
[TBL] [Abstract][Full Text] [Related]
5. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
6. Hypophysectomy reduces the haloperidol-induced changes in striatal dopamine receptor density.
Hruska RE; Pitman KT
Eur J Pharmacol; 1982 Nov; 85(2):201-5. PubMed ID: 7151867
[TBL] [Abstract][Full Text] [Related]
7. Prolactin and estradiol increase striatal dopamine receptor density in intact, castrated and hypophysectomized rats.
Di Paolo T; Poyet P; Labrie F
Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):377-82. PubMed ID: 6891804
[TBL] [Abstract][Full Text] [Related]
8. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
Allen RM; Lane JD; Brauchi JT
Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
10. Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity.
Rupniak N; Hong M; Mansfield S; Fleminger S; Dyer R; Jenner P; Marsden CD
Eur J Pharmacol; 1983 Sep; 93(3-4):195-200. PubMed ID: 6139285
[TBL] [Abstract][Full Text] [Related]
11. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.
Simpson MD; Jenner P; Marsden CD
Biochem Pharmacol; 1986 Oct; 35(20):3501-6. PubMed ID: 3768037
[TBL] [Abstract][Full Text] [Related]
12. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
[TBL] [Abstract][Full Text] [Related]
13. Influence of hypophysectomy on dopamine receptors and dopaminergic behaviors.
Hruska RE
Pharmacol Biochem Behav; 1987 Aug; 27(4):629-33. PubMed ID: 3659087
[TBL] [Abstract][Full Text] [Related]
14. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
Morgan DG; Sinha YN; Finch CE
Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
[TBL] [Abstract][Full Text] [Related]
15. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
[TBL] [Abstract][Full Text] [Related]
16. Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat.
Fields JZ; Gordon JH
Brain Res Bull; 1991 Apr; 26(4):549-52. PubMed ID: 1831063
[TBL] [Abstract][Full Text] [Related]
17. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
Lynch MR
Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
[TBL] [Abstract][Full Text] [Related]
18. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
Pittman KJ; Jakubovic A; Fibiger HC
Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
[TBL] [Abstract][Full Text] [Related]
19. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
De Veaugh-Geiss J; Devanand DP; Carey RJ
Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S
Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
